The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -23.62%.However, over the last six months, we can see a stronger performance of -33.39%. Over the last 30 days, the price of IDYA has fallen by 7.98%. And in the last five days, it has surged by 12.49%.
Ideaya Biosciences Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $44.42 on 07/31/24 and the lowest value was $13.45 on 04/09/25.
52-week price history of IDYA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Ideaya Biosciences Inc’s current trading price is -55.81% away from its 52-week high, while its distance from the 52-week low is 45.95%. The stock’s price range during this period has varied between$13.45 and $44.42. The Ideaya Biosciences Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.99 million for the day, a figure considerably higher than their average daily volume of 1.3 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Ideaya Biosciences Inc (IDYA) has experienced a quarterly decline of -4.99% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.72B and boasts a workforce of 131 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 20.24, with a change in price of -5.75. Similarly, Ideaya Biosciences Inc recorded 1,147,955 in trading volume during the last 100 days, posting a change of -22.66%.
IDYA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for IDYA stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.
IDYA Stock Stochastic Average
Ideaya Biosciences Inc’s raw stochastic average for the past 50 days is presently 77.44%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 60.95%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 36.72% and 27.79%, respectively.
